Display options
Cite
Zhang J, Yan X, Tian Y, et al. Synthesis of a New Water-Soluble Melatonin Derivative with Low Toxicity and a Strong Effect on Sleep Aid. ACS Omega. 2020;5(12):6494-6499doi: 10.1021/acsomega.9b04120.
Zhang, J., Yan, X., Tian, Y., Li, W., Wang, H., Li, Q., Li, Y., Li, Z., & Wu, T. (2020). Synthesis of a New Water-Soluble Melatonin Derivative with Low Toxicity and a Strong Effect on Sleep Aid. ACS omega, 5(12), 6494-6499. https://doi.org/10.1021/acsomega.9b04120
Zhang, Jianghong, et al. "Synthesis of a New Water-Soluble Melatonin Derivative with Low Toxicity and a Strong Effect on Sleep Aid." ACS omega vol. 5,12 (2020): 6494-6499. doi: https://doi.org/10.1021/acsomega.9b04120
Zhang J, Yan X, Tian Y, Li W, Wang H, Li Q, Li Y, Li Z, Wu T. Synthesis of a New Water-Soluble Melatonin Derivative with Low Toxicity and a Strong Effect on Sleep Aid. ACS Omega. 2020 Mar 16;5(12):6494-6499. doi: 10.1021/acsomega.9b04120. eCollection 2020 Mar 31. PMID: 32258885; PMCID: PMC7114735.
Copy Download .nbib Format: NLM
Share it on

ACS Omega. 2020 Mar 16;5(12):6494-6499. doi: 10.1021/acsomega.9b04120. eCollection 2020 Mar 31.

Synthesis of a New Water-Soluble Melatonin Derivative with Low Toxicity and a Strong Effect on Sleep Aid.

ACS omega

Jianghong Zhang, Xu Yan, Yunpeng Tian, Wanyun Li, Haiyang Wang, Qinbin Li, Yufei Li, Zhu Li, Ting Wu

Affiliations

  1. Xiamen Nuokangde Biological Technology Co., Ltd., Xiamen 361006, China.
  2. School of Chemistry, Sun Yat-Sen University, Guangzhou 510275, China.
  3. Cancer Research Center, Medical School, Xiamen University, Xiamen 361005, China.
  4. Mingguang People's Hospital, Mingguang City 239400, China.
  5. University Affiliated Keji High School, Xiamen 361005, China.

PMID: 32258885 PMCID: PMC7114735 DOI: 10.1021/acsomega.9b04120

Abstract

A new melatonin sulfonate derivative sodium 4-(3-(2-acetamidoethyl)-5-methoxy-1

Copyright © 2020 American Chemical Society.

Conflict of interest statement

The authors declare the following competing financial interest(s): Xiamen Nuokangde Biological Technology Co., Ltd is the initi-ator and funding provider of this work; Dr. Zhu Li is chairman of the co

References

  1. Int J Mol Sci. 2018 May 18;19(5): - PubMed
  2. Science. 2007 Nov 16;318(5853):1144-6 - PubMed
  3. Int J Mol Sci. 2013 Apr 12;14(4):8093-121 - PubMed
  4. PLoS One. 2014 Jan 09;9(1):e85311 - PubMed
  5. Science. 1980 Dec 12;210(4475):1267-9 - PubMed
  6. Horm Behav. 2013 Jun;64(1):1-7 - PubMed
  7. Eur J Pharm Biopharm. 2017 Mar;112:58-66 - PubMed
  8. Clin Drug Investig. 2016 Mar;36(3):169-75 - PubMed
  9. Neurosci Lett. 2004 Jul 8;364(3):199-202 - PubMed
  10. Methods Enzymol. 2018;602:211-228 - PubMed
  11. J Pineal Res. 2018 Aug;65(1):e12478 - PubMed
  12. Nature. 1982 May 6;297(5861):23-7 - PubMed
  13. Neuropharmacology. 2015 Dec;99:187-95 - PubMed
  14. J Pineal Res. 2008 Oct;45(3):229-34 - PubMed
  15. J Pineal Res. 1994 May;16(4):198-201 - PubMed
  16. J Pineal Res. 2004 Jan;36(1):1-9 - PubMed
  17. Nat Rev Neurosci. 2014 Jul;15(7):443-54 - PubMed
  18. Curr Med Chem. 2010;17(36):4462-81 - PubMed
  19. BMC Cell Biol. 2009 Feb 13;10:10 - PubMed
  20. Drug Deliv. 2016 Jun;23(5):1594-607 - PubMed
  21. Br J Pharmacol. 2006 Jan;147 Suppl 1:S72-81 - PubMed
  22. J Pineal Res. 1999 Oct;27(3):139-44 - PubMed
  23. Toxicol Appl Pharmacol. 2015 Apr 15;284(2):227-35 - PubMed
  24. J Pineal Res. 2014 May;56(4):371-81 - PubMed
  25. Nat Clin Pract Neurol. 2008 Aug;4(8):436-47 - PubMed
  26. Sleep Med Rev. 2005 Feb;9(1):11-24 - PubMed
  27. Cells. 2019 Jul 05;8(7): - PubMed
  28. Org Lett. 2009 May 21;11(10):2049-52 - PubMed
  29. Endocrine. 2005 Jul;27(2):179-88 - PubMed
  30. Adv Pharm Bull. 2015 Sep;5(3):329-34 - PubMed

Publication Types